The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 18.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (19 analysts) rates it none, with a mean price target of $107.
Qualys, Inc.
QLYS · Nasdaq · USD · Market cap $6.3B · 2,683 employees
Qualys, Inc.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 23:00 UTC · 17 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Qualys, Inc. holds its Distribution at $183.06. Consolidating, no directional conviction, held for 34 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 34 days |
| Price at the screen | $183.06 |
| Valuation | 31.73 trailing · 21.72 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.62 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 4.77% | Below 33% | Interest-bearing debt is just 4.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 14.94% | Below 33% | Cash held in interest-bearing accounts and securities is 14.9% of assets, under the one-third limit. | Pass |
| Receivables | 38.47% | Below 49% | Money owed to the company is 38.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 3.77% | Below 5% | Only 3.8% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 7.7% margin of safety to the base estimate.
Third-party analyst targets: 18 covering, consensus Hold. The average target sits −4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCloud security tool trading above its targets
Picture a firm whose software quietly checks the digital locks on networks for banks, retailers and governments every hour of the day. Qualys runs that service from the cloud, yet the shares sit above our fair value at a 2 percent premium and 18 analysts carry a median target well below the current price.
The business posts a solid 29 percent profit margin and 38 percent return on equity, with revenue rising 10 percent a year. Those numbers look respectable on a 19.3 times forward earnings multiple, but the lack of any margin of safety and the hold consensus from the street leave no real opportunity on the table right now.
Valuation sits at the heart of the concern, because even strong returns can fade if growth stays modest and cheaper rivals keep taking ground. The ethical screen clears without issue. Analysis, not advice.
| Forward P/E | 21.7xpriced for continued growth |
| Trailing P/E | 31.7xa premium valuation |
| EPS, trailing | 5.77 |
| EPS, forward | 8.43 |
| Revenue growth | +11.0%steady growth |
| Profit margin | 29.4%healthy profit margins |
| Return on equity | 38.6%an exceptional return on shareholder capital |
| FCF yield | 3.86% |
| Debt to equity | 0.09minimal debt: a conservative balance sheet |
| Current ratio | 1.38adequate liquidity, worth monitoring |
| Beta | 0.62steadier than the market |
| Short interest, float | 0.15% |
| 52-week range | 74.51 - 201.54 |
| Market cap | $6.3B |
| Employees | 2,683 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeQLYS trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 43.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (19 analysts) rates it none, with a mean price target of $107.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (19 analysts) rates it none, with a mean price target of $107.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 3 May2024 | Tommy Tuberville | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $91.53 | +20.9% | · | $1,209 | +20.9% |
| 2 months | $76.20 | +45.2% | · | $1,452 | +45.2% |
| 3 months | $96.99 | +14.1% | · | $1,141 | +14.1% |
| 6 months | $152.31 | -27.4% | · | $726 | -27.4% |
| 1 year | $141.72 | -21.9% | · | $781 | -21.9% |
| 2 years | $136.66 | -19.0% | · | $810 | -19.0% |
| 3 years | $128.12 | -13.6% | · | $864 | -13.6% |
| 5 years | $102.87 | +7.6% | · | $1,076 | +7.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever QLYS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.